The cause of prolonged neutropenia was considered to be the drug interaction between venetoclax and azoles, which are moderate-to-strong CYP3A4 inhibitors (Agarwal et al., 2017), and high serum venetoclax levels have been reported in Asian subjects (Cheung et al., 2018). This evidence concerns the gene CYP3A4 and neutropenia.